Navigating the pathway to first in human – A case study of a novel cell therapy

Tune into this webinar to learn how the Cell and Gene Therapy Catapult can provide you with essential non-clinical and health economic support to help progress your ATMP from the pre-clinical stage through to first in human clinical trials.

Watch the Webinar

Please provide your details to gain access.

The Cell and Gene Therapy Catapult takes your data very seriously. By using this form you are consenting to the processing of your personal data as per ourprivacy policy.

In this webinar, the Cell and Gene Therapy Catapult’s Non-clinical and Health Economics and Market Access teams illustrate how a non-clinical programme is designed, and how to incorporate health economics into the clinical development plan at an early-stage to optimise the adoption potential of an advanced therapy. This is part one of a series of two webinars highlighting key considerations for the successful translation of advanced therapies.

You will gain an in-depth understanding of how non-clinical studies provide scientific insight into potential efficacy and safety of an advanced therapy, and why they are critical to assess the risk:benefit relationship with clinical relevance. The importance of incorporating commercial considerations into the early-stage clinical strategy will also be highlighted for its value in helping to overcome the high adoption barriers faced by advanced therapies when they come to market.

Who should watch: Therapy developers who are on the clinical development path and looking for support to increase the adoption potential of their ATMP .